The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Ford filed two patents to make EV charging adoption quicker, cheaper and easier.
Toyota is partnering with petroleum firms to develop carbon-neutral fuels and make them available in Japan by 2030.
PayPal is harnessing purchase data to join the ever-growing list of companies with a new offshoot advertising business.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Just what, exactly, would Sony and Apollo Global Management be getting out of a Paramount Global acquisition?
If 3 million people pass through security checkpoints Friday, it’d mark the busiest travel day ever recorded.
The average age of cars and light trucks reached a record high of 12.6 years in 2024, up by roughly two months from last year.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
The retailer will cut prices on up to 5,000 grocery items to keep pace with lower-cost rivals like Walmart.
A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.
The service has grown to 74 million monthly active users, a bigger audience than the Max paid-subscription platform.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.